Telephone assessment of functioning and well-being following stroke: Is it feasible?

Journal of Stroke and Cerebrovascular Diseases

Volumn 11, Issue 2, 2002, Pages 80-87

  Goldstein, Larry B ^a   Lyden, Patrick ^b   Mathias, Susan D ^c   Colman, Shoshana S ^d   Pasta, David J ^e   Albers, Gregory ^f   Atkinson, Richard ^g   Kelley, Gordon ^h   Ng, Ken ⁱ   Rylander, Anders ^j  

^a DURHAM VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Ovation Research Group   (United States)

^d Lewin Group   (United States)

^e DMA Corporation   (United States)

^f Stanford Medicine Children s Health   (United States)

^g Mercy General Hospital   (United States)

^h Neurology Consultants   (United States)

ⁱ Ocala Neurological Diagnostic Center   (United States)

^j ASTRAZENECA R AND D   (Sweden)

more..

Author keywords

Health utilities index; Outcome; QALY; Quality of life; Stroke

Indexed keywords

ADULT; AGED; APHASIA; ARTICLE; CAREGIVER; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMETRY; RELIABILITY; STROKE; TELEPHONE; VALIDATION PROCESS; WELLBEING;

EID: 0036522491     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1053/jscd.2002.126691     Document Type: Article

References (28)

1. Marler JR, Brott T, Broderick J, et al. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Samsa GP, Matchar DB, Goldstein LB, et al. Utilities for major stroke: Results from a survey preferences among persons at increased risk for stroke. Am Heart J 1998;136:703-713.
3. Bergner M, Bobbitt RA, Carter WB, et al. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981;19:787-805.
4. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
5. Williams LS: Health-related quality of life outcomes in stroke. Neuroepidemiology 1998;17:116-120.
6. The EuroQol Group: EuroQol - A new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
7. Feeny D, Torrance GW, Furlong W: Multi-attribute health status classification systems: Health Utilities Index. Pharmacoeconomics 1995;7:490-502.
8. Dorman PJ, Slattery J, Farrell B, et al. A randomised comparison of the EuroQol and Short Form-36 after stroke. United Kingdom collaborators in the International Stroke Trial. BMJ 1997;315:461.
9. Viitanen M, Fugl-Meyer KS, BernspŒng B, et al. Life satisfaction in long-term survivors after stroke. Scand-J-Rehabil Med 1988;20:17-24.
10. Sneeuw KCA, Aaronson NK, De Haan RJ, et al. Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke 1997;28:1541-1549.
11. Mathias SD, Bates MM, Pasta DJ, et al. Use of the health utilities index with stroke patients and their caregivers. Stroke 1997;28:1888-1894.
12. Nelson LM, Longstreth WT, Koepsell TD, et al. Proxy respondents in epidemiologic research. Epidemiol Rev 1990;12:71-86.
13. Dorman P, Slattery J, Farrell B, et al. Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. Stroke 1998;29:63-68.
14. Robinson RG, Bolduc PL, Kubos KL, et al. Social functioning assessment in stroke patients. Arch Phys Med Rehabil 1985;66:496-500.
15. AbuRahma AF, Robinson P, Holt SM, et al. Perioperative and late stroke rates of carotid endarterectomy contralateral to carotid artery occlusion - Results from a randomized trial. Stroke 2000;31:1566-1571.
16. Grootendorst P, Feeny DH, Furlong W: Does it matter whom and how you ask? Inter- and intra-rater agreement in the Ontario Health Survey. J Clin Epidemiol 1977;50:127-136.
17. Mahoney FI, Barthel DW: Functional evaluation: The Barthel Index. Md State Med J 1965;14:61-65.
18. Wade DT, Collins C: The Barthel ADL Index: A standard measure of physical disability. Int Disabil Stud 1988;10:64-67.
19. Feeny DH, Torrance GW, Furlong WJ: Health Utilities Index. In: Spiker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers, 1996;239-252.
20. Lyden P, Jacoby M, Schim J, et al. The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T). Neurology 2001;57:1199-1205.
21. Torrance GW, Gurlon W, Feeny D, et al. Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics 1995;7:503-520.
22. Cicchetti DV, Sparrow SA: Developing criteria for establishing interrater reliability of specific items: Applications to assessment of adaptive behavior. Am J Ment Defic 1981;86:127-137.
23. Wade DT, Skilbeck CE, Hewer RL: Predicting Barthel ADL score at 6 months after acute stroke. Arch Phys Med Rehabil 1983;64:24-28.
24. Granger CV, Dewis LS, Peters NC, et al. Stroke rehabilitation: Analysis of repeated Barthel Index measures. Arch Phys Med Rehabil 1979;60:14-17.
25. Rothman ML, Williams KHR: Validity of the Health Utilities Index in evaluating therapies for acute stroke. Qual Life Res 1997;6:710 (abstr).
26. Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures. A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999;15:141-155.
27. Grootendorst P, Feeny DH, Furlong W: Health Utilities Index Mark 3: Evidence of construct validity for stroke and arthritis in a population health survey. Med Care 2000;38:290-299.
28. Duncan PW, Wallace D, Lai SM, et al. The Stroke Impact Scale Version 2.0. Evaluation, reliability, validity and sensitivity to change. Stroke 1999;30:2131-2140.